Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors - Test2 - elhamkhani - TriplyDB

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

http://www.wikidata.org/entity/Q24538483

about

Adeno-associated Virus as a Mammalian DNA Vector Parvovirus glycan interactions Structural Insights into Adeno-Associated Virus Serotype 5 Recombinant adeno-associated virus: efficient transduction of the rat VMH and clearance from blood.Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence.Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6 The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9 Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries.Cardiovascular gene therapy: current status and therapeutic potential.Self-complementary adeno-associated virus serotype 6 mediated knockdown of ADAMTS4 induces long-term and effective enhancement of aggrecan in degenerative human nucleus pulposus cells: A new therapeutic approach for intervertebral disc disorders.New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro.Gene therapy in wound healing: present status and future directions.Novel vectors for in vivo gene delivery to vascular tissue.A review of gene and stem cell therapy in cutaneous wound healing.Wound coverage technologies in burn care: novel techniques Designing heart performance by gene transfer.Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.Cardiac gene therapy: are we there yet?In vivo tissue-tropism of adeno-associated viral vectors.Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway.Gene-therapy delivery strategies in cardiology.Impact of transduction towards the proliferation and migration as well as the transduction efficiency of human umbilical cord-derived late endothelial progenitor cells with nine recombinant adeno-associated virus serotypes.Transcytosis in the blood-cerebrospinal fluid barrier of the mouse brain with an engineered receptor/ligand system.Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous Injection.Intra-arterial targeted islet-specific expression of Sirt1 protects β cells from streptozotocin-induced apoptosis in mice.Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.Proteolytic mapping of the adeno-associated virus capsid.Freeze-thaw increases adeno-associated virus transduction of cells.AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier.AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro.

P2860

Q26782605-111D6924-0BF0-4DF5-9CE5-7EDF482C6D46 Q26858992-8B27F43A-D4C7-4411-98F3-E11E2F42D4A4 Q27679454-130464AA-D2BB-4E21-847C-2171496076D2 Q33654870-C2CEA28C-F858-4A6B-90A1-F09945890804 Q34302122-35619E0A-6FB4-4ECA-8AA7-5801651E83B9 Q35024289-410DE1C3-E6AC-4E2A-A1F7-F22A6ECB5B2B Q35101411-BF5F5D6A-A2D6-4FBC-B276-3BC1B8E067A5 Q35140088-D29CA5F6-E54A-4E76-AF73-9B3CA3D08DDF Q35971198-1C9A49F0-B19E-473A-8081-606CC7FE9A6E Q35995220-34ACA055-F2DF-440F-BCCF-6185421043BA Q36282602-0C558157-57E1-4B88-808B-06D04322B7AE Q36385632-E5FEC7E2-61E4-4EE8-9787-4D1076AADF02 Q36541150-0CD5CF0E-293B-4E5D-A2A9-C3D37B9E7005 Q36575417-C8D9F909-C9CF-4F7E-8304-902173A41A4C Q36842711-4C0E6666-A40F-470B-A490-CD6CBD8F49D1 Q37207988-BC263E37-D9C9-42EC-97F5-D9F1F1F52C9D Q37284849-5CCF12D6-31B9-44E7-A498-EC7A018E8957 Q37299072-9489D0AA-B5FF-4B3F-8C1B-09B8DBC4C695 Q37536677-1C41514D-7A38-4FFD-81C5-11EF8BFE6720 Q38820937-9F00A77F-4E51-49D9-BE31-97D987074078 Q38824171-DC1579B3-6E00-4E7C-8896-08965665615F Q39644453-9459851E-8658-433B-87A7-D02F61078582 Q40119187-B58EE5D7-3827-4330-9317-8160A2F18B04 Q40854030-BDBE028D-F947-4FE2-B1D5-BE1361F7877C Q41184303-22A6EF2A-B876-4DDA-8C83-41532952D35A Q41375421-97FCFE0B-7796-45E9-95ED-B913A13A5FE8 Q41681638-C80A64F3-A3AC-497C-85EC-B019947504A6 Q42066164-16555855-F40D-4C88-90F5-C277837026C9 Q42941986-8060BA35-F615-4D84-9A09-19AEA1AEF6C4 Q45419295-5B53CE85-8318-43E4-B420-21E610992E93 Q45859037-3B87D22F-1D07-4E9A-8EA5-63725BA3CC30 Q45875010-BF65CD76-863F-4E88-91E6-96DCC613DBAE Q47117976-04E9F90D-997C-4F7B-8C98-C524ABA197D6

P2860

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

http://www.wikidata.org/entity/Q24538483

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@ast

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@en

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@nl

type

label

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@ast

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@en

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@nl

prefLabel

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@ast

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@en

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@nl

P1433

Q24538483-DD2CB369-6D92-44D7-9B1D-619C76419C82

P1476

Q24538483-DA810064-C76F-4B4A-BB27-A578D52DD60C

P2093

Q24538483-09762317-4D6F-4ADB-B37A-5D4EB3EF4EB3

Q24538483-185E82B0-3C2C-4AD7-BCB6-81615993EEAE

Q24538483-32F07089-9725-4E98-84E9-02ED94C133D2

Q24538483-3B2D0009-A09F-47A3-BC19-D328116F8D2B

Q24538483-3FAA91EA-B209-4000-A1CD-B99A0CA1DC95

Q24538483-6D8640E4-2427-4937-93F0-3280F6F61C01

Q24538483-7AC1C685-5BD0-4D68-908B-EC8CC6FCA5ED

Q24538483-7C7504B0-7A8F-4AB3-B69F-FE92B96B7D2A

Q24538483-97414CB6-0BFB-4175-A8B1-FEA7FD51F0C8

Q24538483-D33BD943-3B83-429C-89D2-7D0019008921

P2860

Q24538483-130EBEC0-364B-410D-9569-EECAEBF083AE

Q24538483-17DA4877-D2DA-40D5-9B52-2EE2A27FD6E4

Q24538483-1F33820F-27AA-4B43-B1ED-FC9C1CE62003

Q24538483-20CF4ED3-C160-47EB-ACD2-E5B73B3EC88A

Q24538483-2585B783-723B-4C96-BB68-E53D3267A9B0

Q24538483-3172286E-B860-4447-820E-11E0554DB402

Q24538483-37891B70-4549-4808-978B-5CD60F37A13C

Q24538483-38E06093-6A63-4F27-9B2D-8BF194A4A68E

Q24538483-39E9D44D-20E1-4385-AE5E-FA6F4C6AD8BC

Q24538483-41ECFCCF-151B-410B-9407-8129B7E380E1

P304

Q24538483-A124AA36-C814-46CE-93EF-12289B3E43E1

P31

Q24538483-4B89DE38-7D03-4EFE-A2ED-BD1221A28DC9

P356

Q24538483-2A9E0636-B349-44E2-BAE4-BA35EEF21211

P407

Q24538483-14E69659-9632-4E25-9AF7-AC8F986A8B67

P433

Q24538483-9592C666-10A3-4E0E-BF7B-00C6CFB0ED77

P478

Q24538483-00625009-294C-4F80-96E6-DCF1FD41E070

P50

Q24538483-9150AD25-0DEF-4FAB-948E-34FC4F2AC413

Q24538483-D126946C-E42A-4CE7-8D8F-8EE17C73DC03

P577

Q24538483-C028D3F6-0066-4013-88BE-8607BF1EAA08

P5875

Q24538483-F73828FD-F527-470C-B16C-67F99FCB5CF9

P698

Q24538483-E1B10913-AD12-4672-8644-BCB8292A4F2E

P921

Q24538483-410088E3-C6EC-426B-AE78-C18DB8687B82

Q24538483-D5279FEA-DDDB-4E33-B7C4-F43435B8DDC8

P932

Q24538483-C2985D3D-F1AD-4851-A12E-2C3EE58B8B8C

P356

HUM.2005.16.235

P1433

Human Gene Therapy

P1476

Efficient transduction of vasc ...... virus serotype 1 and 5 vectors

@en

P2093

Anupam Agarwal

http://www.w3.org/2001/XMLSchema#string

C Craig Tisher

http://www.w3.org/2001/XMLSchema#string

Kenneth I Berns

http://www.w3.org/2001/XMLSchema#string

Kirsten M Madsen

http://www.w3.org/2001/XMLSchema#string

Mark A Atkinson

http://www.w3.org/2001/XMLSchema#string

Matthias Kapturczak

http://www.w3.org/2001/XMLSchema#string

Olena Y Glushakova

http://www.w3.org/2001/XMLSchema#string

Richard J Samulski

http://www.w3.org/2001/XMLSchema#string

Scott A Loiler

http://www.w3.org/2001/XMLSchema#string

Sergei Zolotukhin

http://www.w3.org/2001/XMLSchema#string

P2860

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells.

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.

Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors.

Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells.

Development of efficient viral vectors selective for vascular smooth muscle cells.

Cloning and characterization of adeno-associated virus type 5.

Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer.

P304

235-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2005.16.235

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Martha Campbell-Thompson

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7973712

http://www.w3.org/2001/XMLSchema#string

P698

15761263

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

1364465

http://www.w3.org/2001/XMLSchema#string